iversity Press, 1983.578-581.
7,Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer′s disease. Am J Psychiatry, 1984, 141:1356-1364.
8,Kiernan RJ, Mueller J, Langston JW, et al. The neurobehavioral cognitive status examination: a quantitative approach to cognitive assessment. Ann Intern Med,1987,107:481-485.
9,Osmon DC, Smet IC, Winegarden B,et al. Neurobehavioral cognitive status examination: its use with unilateral stroke patients in a rehabilitation setting. Arch Phs Med Rehabil, 1992,73:414-418.
10,Faust D, Fogel B. The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis, 1989, 177:25-31.
11,Glosser G, Wolfe N, Kliner-Krenzel L, et al. Cross-cultural cognitive examination performance in patients with Parkinson′s disease and Alzheimer′s disease. J Nerv Ment Dis, 1994, 182: 432-436.
12,Mate-Kole CC, Major A, Lenzer I, et al. Validation of the quick cognitive screening test. Arch Phys Med Rehabil, 1994,75:867-875.
13,Delis DC. Neuropsychological assessment of learning and memory. In: Boller F, Grafman J, eds. Handbook of Neuropsychology. vol.3. New York: Elsevier Science Publishers B.V. (Biomedical Division), 1989.3-30.
14,Chan AS,Salmon DP,Butters N, et al. Semantic network abnormality predicts rate of cognitive decline in patients with probable Alzheimer′s disease. J Int Neuropsychol Soc, 1995, 1:297-303.
15,Chan AS,Butters N,Salmon DP. The deterioration of semantic networks in patients with Alzheimer′s disease: a cross-sectional study. Neuropsychologia, 1997, 35:241-248.
16,Morris JC,Heyman A,Mohs RC,et al. The Consortium to Establish a Registry for Alzheimer′s Disease(CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer′s disease. Neurology, 1989,39:1159-1165.
17,Almkvist O. Neuropsychological features of early Alzheimer′s disease: preclinical and clinical stages. Acta Neurol Scand, 1996, 165 Suppl: 63-71.
18,Pasquier F. Early diagnosis of dementia: neuropsychology. J Neurol, 1999,246:5-15.
19,Francis PT,Palmer AM,Snape M, et al. The cholinergic hypothesis of Alzhemer′s disease: a review of progress. J Neurol Neurosurg Psychiatry, 1999, 66:137-147.
20,Arrieta JL, Artalejo FR. Methodology,results and quality of clinical trials of tacrine in the treatment of Alzheimer disease: a systematic review of the literature. Age Aging, 1998,27:161-179.
上一页 [1] [2] [3] [4] [5] 下一页
《阿尔茨海默病认知功能量表述评》这篇优秀的“
药学”由
知识宝库收集,来源于互联网和会员投稿,仅供参考和学习,文章版权归原作者所有,请在确认获得著作人合法授权后使用。